Author

Mark Andrew Ainsworth 1

1 Odense University Hospital,Odense,Denmark

DISCONTINUATION OF INFLIXIMAB THERAPY IN PATIENTS WITH CROHN’S DISEASE IN SUSTAINED, COMBINED CLINICAL-BIOCHEMICAL-ENDOSCOPIC REMISSION: A DOUBLE-BLINDED, PLACEBO-CONTROLLED, RANDOMIZED CLINICAL TRIAL

Sine Buhl, Casper Steenholdt, Jens Frederik Dahlerup, Tobias Wirenfeldt Klausen, Mark Andrew Ainsworth, Jørgen Jahnsen, Jørn Brynskov, Ole Østergaard Thomsen, Katrine Risager Christensen, Akbar Molazahi, Natalia Pedersen, Niels Thorsgaard, Eva Efsen Dahl, Ida Vind, Hendrika Adriana Linda Kievit, Taina Sipponen, Jan Marsal;;

Item 1 - 1 / 1
1